Celldex Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -0.60%586.741.0%$833.66m
DHRDanaher Corp. -0.41%288.810.7%$641.01m
ISRGIntuitive Surgical, Inc. 1.02%242.780.8%$514.65m
ABTAbbott Laboratories 0.10%109.360.8%$484.19m
MDTMedtronic Plc 0.45%93.700.6%$430.41m
SYKStryker Corp. 0.34%216.521.3%$371.44m
BSXBoston Scientific Corp. -0.01%40.941.0%$310.00m
ALGNAlign Technology, Inc. 2.29%300.616.4%$275.03m
EWEdwards Lifesciences Corp. 0.35%106.490.4%$257.74m
DXCMDexCom, Inc. 3.40%92.121.9%$249.58m
IDXXIDEXX Laboratories, Inc. 1.10%412.283.8%$231.61m
BDXBecton, Dickinson & Co. 0.56%255.641.0%$221.27m
BAXBaxter International, Inc. 1.13%59.251.8%$188.63m
AAgilent Technologies, Inc. -0.78%132.571.7%$175.47m
MTDMettler-Toledo International, Inc. 0.24%1351.005.9%$167.10m

Company Profile

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.